LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
CAS Number
862507-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRBAMLPRKCAAP056120UL 1 Each
Rabbit Anti PRKCA Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Western Blot,IHC,Immunofluorescence)
Sign In for Pricing
View Details ![[KO Validated] PSME3 Rabbit pAb](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS2157157-01 96 Tests
Fc Fragment Of IgG Low Affinity IIIb Receptor (FcgR3B) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details MBS2157157-02 5x 96 Tests
Fc Fragment Of IgG Low Affinity IIIb Receptor (FcgR3B) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details